Loading clinical trials...

The Nordic IBD Treatment Strategy Trial | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT05180175

The Nordic IBD Treatment Strategy Trial

Purpose: To demonstrate that personalised therapy can be delivered to patients with IBD, by treating patients with an increased risk of poor disease course, defined by a serum protein signature at di...

Lead sponsor: Region Örebro County•15 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Association Between LRG and Histologic Remission in Ulcerative Colitis

NCT06372613 · Ulcerative Colitis in Histologic Remission

RECRUITINGPhase 4

Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）

NCT07550673 · Acute Severe Ulcerative Colitis

RECRUITINGPhase 1/2

A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis

NCT07374471 · Ulcerative Colitis (UC)

RECRUITINGNA

Early vs Delayed Surgery for Stricturing CD--a RCT

NCT05421455 · Crohn Disease

RECRUITINGPhase 2

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883 · Inflammatory Bowel Diseases, Crohn's Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 10, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment300

Start dateFeb 2022

Last updatedDec 10, 2025

Condition

Inflammatory Bowel Diseases Ulcerative Colitis Crohn Disease

Locations shown

Hospital Sønderjylland

Aabenraa

Odense University Hospital

Odense

OUH Svendborg Hospital

Svendborg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 10, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions